These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1191 related articles for article (PubMed ID: 30590238)

  • 1. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.
    Titulaer MJ; Höftberger R; Iizuka T; Leypoldt F; McCracken L; Cellucci T; Benson LA; Shu H; Irioka T; Hirano M; Singh G; Cobo Calvo A; Kaida K; Morales PS; Wirtz PW; Yamamoto T; Reindl M; Rosenfeld MR; Graus F; Saiz A; Dalmau J
    Ann Neurol; 2014 Mar; 75(3):411-28. PubMed ID: 24700511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
    Nagata S; Nishimura Y; Mitsuo K
    Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies.
    Zhou L; ZhangBao J; Li H; Li X; Huang Y; Wang M; Zhao C; Lu J; Lu C; Li Y; Quan C
    Mult Scler Relat Disord; 2017 Nov; 18():90-92. PubMed ID: 29141829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of steroid therapy in the acute stage of anti-NMDAR and anti-MOG antibody overlapping encephalitis: a case report and literature review.
    Kondo H; Takeuchi Y; Niwa J; Yoshida K; Takemura N; Hosoyama S; Kaga T; Kaneko K; Mabuchi N
    Front Immunol; 2024; 15():1392992. PubMed ID: 38895128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
    Pérez CA; Agyei P; Gogia B; Harrison R; Samudralwar R
    J Neuroimmunol; 2020 Feb; 339():577124. PubMed ID: 31837635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies.
    Rojc B; Podnar B; Graus F
    J Neuroimmunol; 2019 Mar; 328():86-88. PubMed ID: 30599296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report.
    Cao L; Ren L; Huang X
    Medicine (Baltimore); 2021 Jan; 100(1):e24234. PubMed ID: 33429822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.
    Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C
    Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics of Anti-
    Zhang S; Yang Y; Liu W; Li Z; Li J; Zhou D
    Front Immunol; 2022; 13():857443. PubMed ID: 35837405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
    Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
    Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report.
    Aoe S; Kokudo Y; Takata T; Kobara H; Yamamoto M; Touge T; Deguchi K; Masaki T
    Mult Scler Relat Disord; 2019 Oct; 35():182-184. PubMed ID: 31398656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: Two paradigmatic cases and a review of the literature.
    Foiadelli T; Gastaldi M; Scaranzin S; Franciotta D; Savasta S
    Mult Scler Relat Disord; 2020 Jun; 41():102011. PubMed ID: 32163756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children.
    Hou C; Wu W; Tian Y; Zhang Y; Zhu H; Zeng Y; Peng B; Zheng K; Li X; Chen W
    Mult Scler Relat Disord; 2020 Jul; 42():102018. PubMed ID: 32234601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
    Peschl P; Bradl M; Höftberger R; Berger T; Reindl M
    Front Immunol; 2017; 8():529. PubMed ID: 28533781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: A distinct clinical entity?
    Chen W; Li Q; Wang T; Fan L; Gao L; Huang Z; Lin Y; Xue Q; Liu G; Su Y; Zhang Y
    Mult Scler Relat Disord; 2021 Jul; 52():103020. PubMed ID: 34034214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis.
    Zhou J; Tan W; Tan SE; Hu J; Chen Z; Wang K
    J Neuroimmunol; 2018 Jul; 320():107-110. PubMed ID: 29661538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.